An interesting article and discussion with the Renasas CEO - https://www.mckinsey.com/industries/semiconductors/our-insights/renesass-hidetoshi-shibata-on-leadership-through-difficult-times
McKinsey: Like 5G, Industry 4.0—the Fourth Industrial Revolution—is a big topic. How is Renesas planning to participate in this opportunity?
Hidetoshi Shibata: It is very similar to what we discussed regarding connectivity in 5G and beyond, with one key difference: a focus on AI [artificial intelligence], and what we call endpoint AI in particular. The endpoint represents the true point of action, as opposed to the edge of the cloud. Near-zero latency is critically important in those endpoints. So that is a key focus of our solutions. For example, we provide dynamically configurable hardware architectures that let customers enjoy the benefit of hardware-processing speeds while also providing more flexibility to change the functionality or algorithms.We are also enriching our translator capabilities to effectively port AI models trained on industry-standard networks to our hardware. Toward that end, we are working closely with advanced endpoint-compiler software partners to enable customers to test capabilities purely in the cloud before porting them over to our boards, and then, finally, to implement these seamlessly on our chips.
- Forums
- ASX - By Stock
- BRN
- 2020 BRN Discussion
2020 BRN Discussion, page-26740
-
- There are more pages in this discussion • 2,574 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $361.9M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.5¢ | $139.2K | 709.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
84 | 1825270 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 613134 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
84 | 1825270 | 0.195 |
62 | 1667098 | 0.190 |
32 | 1772636 | 0.185 |
51 | 1549834 | 0.180 |
19 | 618862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 537913 | 20 |
0.205 | 1012585 | 21 |
0.210 | 1378483 | 25 |
0.215 | 533493 | 23 |
0.220 | 678461 | 24 |
Last trade - 10.42am 16/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online